GB2137202B - Novel pharmaceutical compounds - Google Patents
Novel pharmaceutical compoundsInfo
- Publication number
- GB2137202B GB2137202B GB08407765A GB8407765A GB2137202B GB 2137202 B GB2137202 B GB 2137202B GB 08407765 A GB08407765 A GB 08407765A GB 8407765 A GB8407765 A GB 8407765A GB 2137202 B GB2137202 B GB 2137202B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compounds
- novel pharmaceutical
- novel
- compounds
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB08407765A GB2137202B (en) | 1983-03-30 | 1984-03-26 | Novel pharmaceutical compounds |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8308856 | 1983-03-30 | ||
| GB08407765A GB2137202B (en) | 1983-03-30 | 1984-03-26 | Novel pharmaceutical compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8407765D0 GB8407765D0 (en) | 1984-05-02 |
| GB2137202A GB2137202A (en) | 1984-10-03 |
| GB2137202B true GB2137202B (en) | 1987-09-09 |
Family
ID=26285689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB08407765A Expired GB2137202B (en) | 1983-03-30 | 1984-03-26 | Novel pharmaceutical compounds |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2137202B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
-
1984
- 1984-03-26 GB GB08407765A patent/GB2137202B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB2137202A (en) | 1984-10-03 |
| GB8407765D0 (en) | 1984-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR82557B (en) | Novel compounds | |
| DE3466476D1 (en) | External pharmaceutical composition | |
| GR80293B (en) | Pharmaceutical composition | |
| ZA849927B (en) | Novel compounds | |
| ZA842348B (en) | Pharmaceutical compounds | |
| GB8417154D0 (en) | Pharmaceutical composition | |
| GB8305175D0 (en) | Substituted thiopyranopyrimidine pharmaceutical compounds | |
| ZA84631B (en) | Novel compounds | |
| GB8417753D0 (en) | Pharmaceutical compounds | |
| GB2158442B (en) | Cyclovitamin d compounds | |
| GB8332269D0 (en) | Pharmaceutical compounds | |
| GB8711313D0 (en) | 1-23-dihydroxyvitamin d compounds | |
| GB8407735D0 (en) | Pharmaceutical composition | |
| GB2137202B (en) | Novel pharmaceutical compounds | |
| ZA859077B (en) | Pharmaceutical compounds | |
| GB2181126B (en) | Novel pharmaceutical compounds | |
| GB8308414D0 (en) | Pharmaceutical composition | |
| ZA841173B (en) | Novel compounds | |
| ZA845785B (en) | Pharmaceutical unit | |
| IE57161B1 (en) | Novel pharmaceutical compounds | |
| GB8304603D0 (en) | Substituted thiopyranopyrimidine pharmaceutical compounds | |
| GB8319536D0 (en) | Pharmaceutical compounds | |
| GB8330816D0 (en) | Pharmaceutical compounds | |
| GB8330817D0 (en) | Pharmaceutical compounds | |
| GB8317597D0 (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |